
|Articles|September 13, 2000
IScibe and Johnson & Johnson Announce Joint-Market Deal
Advertisement
(SAN MATEO, Calif.)IScribe, Inc., a provider of electronic, hand-held prescription-writing systems for doctors, is expected to announce a joint-market deal with pharmaceutical giant Johnson & Johnson. The Johnson & Johnson sales force will promote iScribe to primary-care doctors and specialists. In exchange, Johnson & Johnson will obtain the right to sponsor advertising and health information on the system. This will include Johnson & Johnson paying a sponsorship fee that will be determined by the number of physicians using the iScribe system. For more information visit www.iscribe.com.
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
New Study Finds No Link Between Contaminated Endoscopes and Bloodstream Infections in 316,000+ Procedures.
2
Defunded and Exposed: How US Aid Cuts and Broken Trust Fueled the 2026 Ebola Crisis
3





